Evidence map›Paper›PMID 29452569›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2018

Up-regulation of SFTPB expression and attenuation of acute lung injury by pulmonary epithelial cell-specific NAMPT knockdown.

Guangliang Bi, Lei Wu, Peixin Huang, Shamima Islam, Daniel P Heruth, Li Qin Zhang, Ding-You Li, Venkatesh Sampath, Weimin Huang, Brett A Simon and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Molecular Mechanisms of Vascular Damage During Lung Injury.Advances in experimental medicine and biology · 2021
    Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 2 countries.

Guangliang BiDepartment of Pediatrics, Children's Mercy, University of Missouri Kansas City School of Medicine, Kansas City, Missouri, USA.
Lei WuDepartment of Pediatrics, Children's Mercy, University of Missouri Kansas City School of Medicine, Kansas City, Missouri, USA.
Peixin HuangDepartment of Pediatrics, Children's Mercy, University of Missouri Kansas City School of Medicine, Kansas City, Missouri, USA.
Shamima IslamDepartment of Pediatrics, Children's Mercy, University of Missouri Kansas City School of Medicine, Kansas City, Missouri, USA.
Daniel P HeruthDepartment of Pediatrics, Children's Mercy, University of Missouri Kansas City School of Medicine, Kansas City, Missouri, USA.
Li Qin ZhangDepartment of Pediatrics, Children's Mercy, University of Missouri Kansas City School of Medicine, Kansas City, Missouri, USA.
Ding-You LiDepartment of Pediatrics, Children's Mercy, University of Missouri Kansas City School of Medicine, Kansas City, Missouri, USA.
Venkatesh SampathDepartment of Pediatrics, Children's Mercy, University of Missouri Kansas City School of Medicine, Kansas City, Missouri, USA.
Weimin HuangDepartment of Neonatology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Brett A SimonDepartment of Anesthesiology, Josie Robertson Surgery Center, Memorial Sloan-Kettering Cancer Center, Weill Cornell Medical College, Cornell University, New York, New York, USA.
Ronald Blaine EasleyDepartment of Pediatrics-Anesthesiology, Baylor College of Medicine, Houston, Texas, USA.
Shui Qing YeDepartment of Pediatrics, Children's Mercy, University of Missouri Kansas City School of Medicine, Kansas City, Missouri, USA.
Sisters of Mercy Health System · USNanfang Hospital · CNUniversity of Missouri–Kansas City · USBaylor College of Medicine · USChangsha Central Hospital · CNChildren's Mercy Hospital · USCornell University · US

Funding

Inflammatory Angiogenesis in the LungR01HL128374 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI SAMPATH, VENKATESH · 2015 to 2020
$1.8M
Novel Role of Pre-B-Cell Colony Enhancing Factor in ALIR01HL080042 · NHLBI · UNIVERSITY OF MISSOURI-COLUMBIA · PI YE, SHUI QING · 2006 to 2010
$1.8M
NHLBI NIH HHS R01 HL080042NHLBI NIH HHS R01 HL128374
6 · The paper itself

Abstract

Although a deficiency of surfactant protein B (SFTPB) has been associated with lung injury, SFTPB expression has not yet been linked with nicotinamide phosphoribosyltransferase (NAMPT), a potential biomarker of acute lung injury (ALI). The effects of Nampt in the pulmonary epithelial cell on both SFTPB expression and lung inflammation were investigated in a LPS-induced ALI mouse model. Pulmonary epithelial cell-specific knockdown of Nampt gene expression, achieved by the crossing of Nampt gene exon 2 floxed mice with mice expressing epithelial-specific transgene Cre or by the use of epithelial-specific expression of anti-Nampt antibody cDNA, significantly attenuated LPS-induced ALI. Knockdown of Nampt expression was accompanied by lower levels of bronchoalveolar lavage (BAL) neutrophil infiltrates, total protein and TNF-α levels, as well as lower lung injury scores. Notably, Nampt knockdown was also associated with significantly increased BAL SFTPB levels relative to the wild-type control mice. Down-regulation of NAMPT increased the expression of SFTPB and rescued TNF-α-induced inhibition of SFTPB, whereas overexpression of NAMPT inhibited SFTPB expression in both H441 and A549 cells. Inhibition of NAMPT up-regulated SFTPB expression by enhancing histone acetylation to increase its transcription. Additional data indicated that these effects were mainly mediated by NAMPT nonenzymatic function via the JNK pathway. This study shows that pulmonary epithelial cell-specific knockdown of NAMPT expression attenuated ALI, in part, via up-regulation of SFTPB expression. Thus, epithelial cell-specific knockdown of Nampt may be a potential new and viable therapeutic modality to ALI.-Bi, G., Wu, L., Huang, P., Islam, S., Heruth, D. P., Zhang, L. Q., Li, D.-Y., Sampath, V., Huang, W., Simon, B. A., Easley, R. B., Ye, S. Q. Up-regulation of SFTPB expression and attenuation of acute lung injury by pulmonary epithelial cell-specific NAMPT knockdown.

Indexed as

Acute Lung InjuryAlveolar Epithelial CellsAnimalsCell Line, TumorCytokinesHistonesHumansMAP Kinase Kinase 4MiceMice, Inbred C57BLNicotinamide PhosphoribosyltransferasePulmonary SurfactantsTumor Necrosis Factor-alphaUp-RegulationCytokinesHistonesMAP Kinase Kinase 4Nicotinamide Phosphoribosyltransferasenicotinamide phosphoribosyltransferase, mousePulmonary SurfactantsTumor Necrosis Factor-alphagene expressionJNK pathwaymouse modelsurfactant proteins B

Identifiers

PMID29452569
PMCPMC5998971
OpenAlexW2786813546

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.